Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a global public
health crisis, for which antiviral treatments are considered mainstream therapeutic …

Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …

Despite aggressive efforts on containment measures for the coronavirus disease 2019
(COVID-19) pandemic around the world, severe acute respiratory syndrome coronavirus 2 …

Objective To investigate the efficacy and safety of antiviral drugs in the treatment of
coronavirus disease 2019 (COVID-19). Methods All clinical trials of antiviral drug treatment …

Abstract Coronavirus disease-2019 (COVID-19), first reported in China during December of
2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

BACKGROUND: Antiviral medications are being given empirically to some patients with
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …

ABSTRACT Introduction Coronavirus Disease 2019 is a contagious infection that has
infected millions worldwide. The objective of this systematic review is to identify studies …

SARS-CoV-2 infection is an acute pneumonia attack caused by a largely-infectious, recently
elicited, and murdered virus with global public health issues and economic problems. Many …

The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …